Envision Pharma Group Acquires doDOC

March 22, 2021

Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.

Buyers
Envision Pharma Group, GHO Capital Partners LLP
Targets
doDOC Corp.
Platforms
Envision Pharma Group
Industry
Software
Location
Massachusetts, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.